CH Biotech R&D Co., Ltd. Stock

Equities

6534

TW0006534001

Agricultural Chemicals

End-of-day quote Taiwan S.E. 18:00:00 2024-06-24 EDT 5-day change 1st Jan Change
84.2 TWD -0.24% Intraday chart for CH Biotech R&D Co., Ltd. -1.98% +4.60%

Financials

Sales 2024 * 1.62B 49.66M 67.74M Sales 2025 * - Capitalization 8.66B 266M 363M
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 5.36 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * -
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
Ch Biotech R&D Co., Ltd. Approves the Appointments of the 4th Remuneration Committee Members CI
CH Biotech R&D Co., Ltd. Announces Audit Committee Changes CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
CH Biotech R&D Co., Ltd.(TWSE:6534) added to Taiwan TAIEX Index CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
CH Biotech R&D Co., Ltd. Approves Cash Dividend for the Second Half of 2023, Payable on April 12, 2024 CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
CH Biotech R&D Co., Ltd. Approves Cash Dividend for the First Half Ended June 30, 2023, Payable on October 18, 2023 CI
CH Biotech R&D Co., Ltd. Appoints Robert James Christopher Clayton as Institutional Director Representative CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
CH Biotech R&D Co., Ltd. Announces Resignation of Brent Randall Smith as Natural-Person Director CI
CH Biotech R&D Co., Ltd. Announces CHB Resignation of Brent Randall Smith as Natural-Person Director CI
More news
1 day-0.24%
1 week-1.98%
Current month-3.00%
1 month-4.64%
3 months-3.22%
6 months+2.06%
Current year+4.60%
More quotes
1 week
83.30
Extreme 83.3
84.70
1 month
82.30
Extreme 82.3
88.70
Current year
78.50
Extreme 78.5
95.00
1 year
71.70
Extreme 71.7
114.50
3 years
41.91
Extreme 41.913
114.50
5 years
38.10
Extreme 38.1035
114.50
10 years
38.10
Extreme 38.1035
184.94
More quotes
Managers TitleAgeSince
Chief Executive Officer - 21-08-31
Founder - 13-11-28
Director of Finance/CFO - 17-10-25
Members of the board TitleAgeSince
Director/Board Member - 15-07-09
Director/Board Member - 14-10-14
Founder - 13-11-28
More insiders
Date Price Change Volume
24-06-25 84.2 -0.24% 22,000
24-06-24 84.4 -0.12% 24,000
24-06-21 84.5 +0.36% 21,250
24-06-20 84.2 +0.72% 34,000
24-06-19 83.6 -2.68% 96,895

End-of-day quote Taiwan S.E., June 24, 2024

More quotes
CH Biotech R&D Co Ltd, located in Taiwan, is a biotechnology company.
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
84.2 TWD
Average target price
89 TWD
Spread / Average Target
+5.70%
Consensus

Quarterly revenue - Rate of surprise